For best viewing, use the latest versions of Google Chrome or Mozilla Firefox

PrEP Use in New York State
Daily HIV pre-exposure prophylaxis (PrEP) is a key component of New York's Ending the Epidemic Initiative. These data show trends in PrEP use in the NYS Medicaid Program beginning in 2012, by counting the number of Medicaid enrollees who filled PrEP prescriptions.
Further reading on initial study methodology and analysis
9,439
NYS Medicaid PrEP beneficiaries | Jan 2012 - Dec 2017
Data ViewSelect visualization type to view
Select Region
Filters

Source: NYS Medicaid Data Mart (Vertica)

Administrative billing data. Interpret with caution
  • 1 Fee for service/Managed care status determined at the time of initial PrEP claim.
  • 2 Ages are calculated at the time of initial Truvada claim for PrEP.
  • 3 Region/Race/Gender based on the latest information as of data extract date.Region based on residence of Medicaid beneficiary. Claims and encounter data are subject to errors and omissions, specifically with regard to the race and ethnicity of recipients.

Additional Notes

  • Beneficiaries counted if filled at least one Truvada prescription in a given analysis time period
  • Count of beneficiaries are not cumulative and cannot be aggregated across time periods. Counts pertain only to the 6 month time period within which they are measured
  • Exclusions
    • Having a diagnosis of HIV (ICD-9 042 or V08 and ICD-10 B20 or Z21) which occurred on two separate encounters, 2 years prior to the first use of Truvada
    • Having a diagnosis of chronic Hepatitis B infection which occurred on two separate encounters, 2 years prior to the first use of Truvada
    • Having pharmacy claims for the following ARV agents during the analysis time period: W5C, W5I, W5J, W5K, W5L,W5M, W5N, W5P, W5Q, W5T, W5U, W5X, W5Z (therapeutic class)
    • Having pharmacy claims for the following HBV agents during the analysis time period: W5F and W5J (therapeutic class)
    • Having HIV diagnosis or HBV diagnosis during the analysis time period.